nPhase, announced the closing of a $30 million Series D funding round led by Viking Global Investors to accelerate the company's AI-native clinical data platform for pharmaceutical sponsors seeking to unlock the full potential of their data and power AI at scale. Viking Global Investors is an investment firm managing more than $54 billion in capital across public and private investments. The financing represents nPhase's first equity capital raise since 2017, reflecting the company's disciplined approach to capital management and its ability to build and expand its business without additional equity financing for nearly a decade.